Ogata et al. (14) developed a single molecule array assay to quantitatively detect SARS-CoV-2 antigens in blood, finding that S1 and N antigens were detectable in 64.06% (41/64) of COVID-19 patients, similar to the result of weeks 2 in this study. This evidence concerns the gene PSMD1 and COVID-19.